2020
DOI: 10.1016/j.jad.2020.03.029
|View full text |Cite
|
Sign up to set email alerts
|

Effects of vitamin D supplementation on depression and some involved neurotransmitters

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
42
0
4

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(47 citation statements)
references
References 60 publications
1
42
0
4
Order By: Relevance
“…The large number of pathological features, identified lately, has stimulated the development of new theories, in an attempt to explain the triggering of clinical symptoms and dysfunctions. One of these most influential neurobiological perspectives is related to dysfunctions of monoaminergic neurotransmitters (serotonin, norepinephrine and dopamine), elucidating the need to enhance the activity of these monoamines (COWEN, 2016;KAVIANI et al, 2020) The proinflammatory condition in individuals with DD exhibits elevated levels of circulating proinflammatory cytokines (IL-1 IT-6 interleukins, tumor necrosis factor alpha (TNF-a) and some soluble interleukin receptors (stimulate the hypothalamic-axis). pituitaryadrenal-HPA), participate in the innate immune response and inflammation, have important metabolic effects, neurotransmitters, neuroendocrine function and neural plasticity, such as the administration of IL-6, which induces depressive behaviors and neutralizes fluoxetine's antidepressant effect in animals experimental (LIU et al, 2017;BERK et al, 2020) The compression of the interface between inflammation and depression has led to new questions and immunological investigations in depressed patients, requiring the development of more effective anti-inflammatory treatments (COWEN, 2016;LIU et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The large number of pathological features, identified lately, has stimulated the development of new theories, in an attempt to explain the triggering of clinical symptoms and dysfunctions. One of these most influential neurobiological perspectives is related to dysfunctions of monoaminergic neurotransmitters (serotonin, norepinephrine and dopamine), elucidating the need to enhance the activity of these monoamines (COWEN, 2016;KAVIANI et al, 2020) The proinflammatory condition in individuals with DD exhibits elevated levels of circulating proinflammatory cytokines (IL-1 IT-6 interleukins, tumor necrosis factor alpha (TNF-a) and some soluble interleukin receptors (stimulate the hypothalamic-axis). pituitaryadrenal-HPA), participate in the innate immune response and inflammation, have important metabolic effects, neurotransmitters, neuroendocrine function and neural plasticity, such as the administration of IL-6, which induces depressive behaviors and neutralizes fluoxetine's antidepressant effect in animals experimental (LIU et al, 2017;BERK et al, 2020) The compression of the interface between inflammation and depression has led to new questions and immunological investigations in depressed patients, requiring the development of more effective anti-inflammatory treatments (COWEN, 2016;LIU et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…According to the researchers, supplementation for eight weeks, dose: 50,000IU, is capable of significantly increasing serum concentrations of 25(OH) and reducing depressive symptoms (YOSAEE et al, 2020;KAVIANI et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…M. Kaviani i wsp. [49], prowadząc badania wśród osób dorosłych ze zdiagnozowaną łagodną lub umiarkowaną postacią depresji, także wykazali zmniejszenie stopnia nasilenia objawów depresyjnych pod wpływem zastosowanej suplementacji witaminą D 3 . Podobne wyniki przedstawili Y.Ch.…”
Section: Suplementacja Witaminą D W Leczeniu Depresjiunclassified
“…Corroborando os achados acima, Kaviani et al (2020) ao suplementar por oito semanas, doses de vitamina D 50.000 UI / 2 semanas, observaram um aumento expressivo nas concentrações séricas de 25 (OH) em pacientes com depressão leve e moderada, tendo assim, uma relevante melhora no perfil da patologia. Vellekkat e Menon (2019) também evidenciaram a eficácia positiva da suplementação oral e parenteral de vitamina D numa metanálise com 948 participantes, em quadro de depressão maior.…”
Section: Vitamina D E Depressãounclassified